Results 131 to 140 of about 12,946 (223)

The Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine [PDF]

, 2011

core   +1 more source

Progress and gaps in poliovirus immunity: Evidence from a serological survey of children aged 6-23 months in high-risk districts of Pakistan. [PDF]

NPJ Vaccines
Hussain I, Khan A, Umer M, Sajid M, Abbas H, Alam MM, Haq MA, Bosan A, Hafiz R, Partridge J, Soofi S.   +10 more
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source

Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial. [PDF]

Vaccines (Basel)
Hu J, Han W, Chu K, Zhang H, Tuo L, Duan X, Li J, Yuan F, Luan C, Pan H, Jiao P.   +10 more
europepmc   +1 more source

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda. [PDF]

Nat Microbiol
Tushabe P, Majumdar M, Carlyle S, Shulman L, Ssekagiri A, Joffret ML, Klapsa D, Cremer J, Arowolo KO, Bujaki E, Bukenya H, EPI Laboratory team, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Hawes KM, Bakamutumaho B, Duizer E, Bessaud M, Bandyopadhyay AS, Macadam A, Byabamazima CR, Martin J, Bwogi J.   +46 more
europepmc   +1 more source

Light-assisted drying enables vaccine stabilization and supports cold-chain-independent distribution. [PDF]

Sci Rep
Tsegaye AA, Suptela AJ, Marriott I, Trammell SR.   +3 more
europepmc   +1 more source

The polio eradication end game: what it means for Europe. [PDF]

, 2014
Ahmed, Q, Heymann, D
core   +1 more source

Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials. [PDF]

Virol J
Terekhov RP, Svotin AA, Korochkina MD, Khodyachikh AA, Varnavskiy MA, Piniaeva AN, Ivin YY, Zhdanov DD, Kozlovskaya LI, Taldaev A.   +9 more
europepmc   +1 more source

Mainstreaming Mistrust: The Shift in US Vaccine Policy Under the Trump Administration. [PDF]

Int J Public Health
Musa S, Estlund A, Berman MA.
europepmc   +1 more source

Antiviral Inactivated Vaccines: Looking to the Past to Face the Future-A Narrative Review. [PDF]

Vaccines (Basel)
Guedes-da-Silva FH, Roncaglia-Pereira VA, Torres S, García MCE, Viana KF, Silva JL, Oliveira AC, Gomes AMO.   +7 more
europepmc   +1 more source